The Chromosome Passenger Complex (CPC) Components and Its Associated Pathways Are Promising Candidates to Differentiate Between Normosensitive and Radiosensitive ATM-Mutated Cells.

Autor: Dietz, Anne¹ (AUTHOR) adietz@bfs.de, Subedi, Prabal¹ (AUTHOR), Azimzadeh, Omid¹ (AUTHOR), Duchrow, Lukas¹ (AUTHOR), Kaestle, Felix¹ (AUTHOR), Paetzold, Juliane¹ (AUTHOR), Katharina Payer, Sarah¹ (AUTHOR), Hornhardt, Sabine¹ (AUTHOR), von Toerne, Christine² (AUTHOR), Hauck, Stefanie M² (AUTHOR), Kempkes, Bettina³ (AUTHOR), Kuklik-Roos, Cornelia³ (AUTHOR), Brandes, Danielle⁴ (AUTHOR), Borkhardt, Arndt⁴ (AUTHOR), Moertl, Simone¹ (AUTHOR), Gomolka, Maria¹ (AUTHOR)

Publikováno v: Biomarker Insights. 10/30/2024, p1-16. 16p.

Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Autor: Koletsa T; Department of Pathology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece. tkoletsa@auth.gr., Kotoula V; Department of Pathology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece.; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloníki, Greece., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece., Manousou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Athens, Greece., Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloníki, Greece., Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Sotiropoulou M; Department of Pathology, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Pentheroudakis G; Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Greece.; Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), Ioannina, Greece., Papoudou-Bai A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece., Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Xepapadakis G; Breast Clinic, REA Hospital, Piraeus, Greece., Zografos G; Breast Unit, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Petraki K; Pathology Department, Metropolitan Hospital, Piraeus, Greece., Pazarli E; Department of Pathology, Papageorgiou Hospital, Thessaloníki, Greece., Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece., Kourea HP; Department of Pathology, University Hospital of Patras, Rion, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Chatzopoulos K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloníki, Greece., Iliadis A; Department of Pathology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece., Markopoulos C; Second Department of Prop. Surgery, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Venizelos V; Breast Unit, Metropolitan Hospital, Piraeus, Greece., Arnogiannaki N; Department of Surgical Pathology, Saint Savvas Anticancer Hospital, Athens, Greece., Kalogeras KT; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloníki, Greece.; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece., Kostopoulos I; Department of Pathology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece., Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research, Aristotle University of Thessaloniki, Thessaloníki, Greece.; Aristotle University of Thessaloniki, Thessaloníki, Greece.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Aug; Vol. 69 (8), pp. 1549-1564. Date of Electronic Publication: 2020 Apr 18.

Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials.

Autor: Zhan, Yanrong¹ (AUTHOR) 220110222844@email.sntcm.edu.cn, Cheng, Xianwen² (AUTHOR), Mei, Pingping³ (AUTHOR), Tan, Shufa⁴ (AUTHOR), Feng, Wenzhe⁵ (AUTHOR) 383686199@qq.com, Jiang, Hua⁵ (AUTHOR)

Publikováno v: BMC Cancer. 7/24/2024, Vol. 24 Issue 1, p1-17. 17p.

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.

Autor: Economopoulou P; Second Department of Internal Medicine, Attikon University Hospital, 1 Rimini St 12462, Haidari, Athens, Greece. Electronic address: panagiota_oiko@hotmail.com., Kotoula V; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, University Campus, Building 17B, 54006, Thessaloniki, Greece; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, University Campus, Building 17B, 54006, Thessaloniki, Greece. Electronic address: vkotoula@auth.gr., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, 18 Hatzikonstanti St, 11524, Athens, Greece. Electronic address: g_koliou@hecog.ondsl.gr., Papadopoulou K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, University Campus, Building 17B, 54006, Thessaloniki, Greece. Electronic address: kyriakipapadopoulou@hotmail.com., Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, 9 Ethnarchou Makariou St, 185 47, Piraeus, Greece. Electronic address: c_christodoulou@yahoo.gr., Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Leof. Stavrou Niarchou, 45500, Ioannina, Greece. Electronic address: gpenther@cc.uoi.gr., Lazaridis G; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Ring Road, Nea Efkarpia, 56450, Thessaloniki, Greece., Arapantoni-Dadioti P; Department of Pathology, Henry Dunant Hospital, 107 Mesogion Av, 11526, Athens, Greece., Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Panepistimioupoli Patron, 26504, Patras, Greece. Electronic address: angkoutr@otenet.gr., Bafaloukos D; First department of Medical Oncology, Metropolitan Hospital, 9 Ethnarchou Makariou St, 185 47, Piraeus, Greece. Electronic address: dimmp@otenet.gr., Papakostas P; Oncology Unit, Hippokration Hospital, 114 Vasilissis Sofias Av, 11527, Athens, Greece. Electronic address: p.papakostas@gmail.com., Patsea H; Department of Pathology, IASSO General Hospital, 264 Mesogion Av, 15562, Athens, Greece., Pavlakis K; Pathology Department, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, 114 Vasilissis Sofias Av, 11527, Athens, Greece. Electronic address: pectasid@otenet.gr., Kotsakis A; Department of Medical Oncology, University General Hospital of Heraklion, Voutes, 71110, Crete, Greece. Electronic address: thankotsakis@hotmail.com., Razis E; Third Department of Medical Oncology, Hygeia Hospital, 4 Erithrou Stavrou St, Marousi, 15123, Athens, Greece. Electronic address: e.razis@hygeia.gr., Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece., Samantas E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Timiou Stavrou, 14564, Kifisia, Athens, Greece. Electronic address: epsam@otenet.gr., Kalogeras KT; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, University Campus, Building 17B, 54006, Thessaloniki, Greece; Translational Research Section, Hellenic Cooperative Oncology Group, 18 Hatzikonstanti St, 11524, Athens, Greece. Electronic address: k_kalogeras@hecog.ondsl.gr., Economopoulos T; Second Department of Internal Medicine, Attikon University Hospital, 1 Rimini St 12462, Haidari, Athens, Greece. Electronic address: economopoulosth@ath.forthnet.gr., Psyrri A; Second Department of Internal Medicine, Attikon University Hospital, 1 Rimini St 12462, Haidari, Athens, Greece. Electronic address: psyrri237@yahoo.com., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, University Campus, Building 17B, 54006, Thessaloniki, Greece; Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. Electronic address: fountzil@auth.gr.

Publikováno v: Translational oncology [Transl Oncol] 2019 May; Vol. 12 (5), pp. 739-748. Date of Electronic Publication: 2019 Mar 14.

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

Autor: Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece., Lazaridis G; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece., Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece., Kouvatseas G; Health Data Specialists Ltd, Athens, Greece., Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece., Kotoula V; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Batistatou A; Department of Pathology, Ioannina University Hospital, Ioannina, Greece., Bobos M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Tsolaki E; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Papadopoulou K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece., Papakostas P; Oncology Unit, Hippokration Hospital, Athens, Greece., Pervana S; Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece., Petraki K; Pathology Department, Metropolitan Hospital, Piraeus, Greece., Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece., Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece., Psyrri A; Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece., Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece., Kalogeras KT; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece., Kalofonos HP; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece., Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.; Aristotle University of Thessaloniki, Thessaloniki, Greece.

Publikováno v: PloS one [PLoS One] 2018 Dec 06; Vol. 13 (12), pp. e0207707. Date of Electronic Publication: 2018 Dec 06 (Print Publication: 2018).